Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: Cron | Vintage Vibes

Cronos Stock Is Getting New Life as Shares Hit a 6-Month High

Cronos (CRON) has demonstrated robust technical momentum, with shares up more than 20% over the past year. CRON maintains a 100% “Buy” rating from Barchart. Revenue is projected to grow 39% this year and 15.78% next year, supporting positive sentiment from analysts and investors. The company focuses on brand growth,...

Barchart

Cronos Group Q1 Earnings Call Highlights

Cronos Group (NASDAQ:CRON) reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter. Chairman, President and CEO Mike Gorenstein said Crono

MarketBeat

4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Cannabis Stocks I Would Flat-Out Avoid In 2024, and One I Would Buy

The cannabis industry is expanding rapidly, but only a few cannabis companies can be winners.

Barchart

CRON, DOLE or MOS: Which Agriculture Stock Is Set to Bloom?

Despite economic challenges, the agricultural sector is set to stay strong with ongoing government support, advanced technology integration, and a focus on innovation aimed toward operational efficiency. In light of these industry tailwinds, which agricultural stock among Cronos Group (CRON), The Mosaic Company (MOS), and Dole plc (DOLE) is most…

StockNews.com

2 Agriculture Stocks to Buy in August 2023, 1 to Sell

The agriculture industry is well-positioned for solid growth thanks to the rise in global population, and robust demand for food. To that end, buying fundamentally strong agriculture stocks Archer-Daniels-Midland (ADM) and AGCO Corporation (AGCO) could be wise. However, it could be wise to sell Cronos Group (CRON), given its weak…

StockNews.com

Cronos Group (CRON) vs. ICL Group (ICL): Which Stocks Is a Better Buy?

The agriculture industry is poised for long-term growth, supported by the rapid adoption of agricultural mechanization and government support. While leading agriculture stocks Cronos Group (CRON) and ICL Group (ICL) should benefit from the industry tailwinds, let us determine which stock is the better buy.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Should You Buy Shares of Cronos Group (CRON) in July?

Cannabis producer Cronos Group (CRON) is experiencing turbulent times with weakening sales and losses. So, will it be worth investing in the stock now? Read on.

StockNews.com

Cronos Group (CRON) vs. MariMed (MRMD): Which Stock Are Investors Buying?

With evolving food consumption trends, favorable government policies and funding, and the adoption of cutting-edge technologies, the agricultural industry is well-placed to experience significant growth in the long run. So, let’s compare prominent agriculture stocks Cronos Group (CRON) and MariMed (MRMD) to identify which is gaining immense popularity among investors.…

StockNews.com

Is Cronos Group (CRON) a Good Buy?

Despite the growing market for recreational cannabis, Cronos Group (CRON) has failed to surpass its consensus EPS and revenue estimates during the first quarter. However, given its substantial cash reserves and no long-term debt, is CRON a good buy now? Keep reading.

StockNews.com

Sell the Farm on These 4 Cannabis Stocks

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

StockNews.com

3 Agriculture Stocks to Feed Your Portfolio in 2023 And 1 to Sell

The rapid adoption of innovative technologies and growing sustainability and vertical farming initiatives should boost the global agriculture market. Hence, fundamentally strong agricultural stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), and Dole (DOLE) could be ideal buys now. However, considering the macro headwinds, fundamentally weak Cronos Group (CRON) might be best avoided.…

StockNews.com

4 Agriculture Stocks With Room to Grow in 2023 and 1 to Sell

The agriculture industry is evoling amid the adoption of innovative technologies. The industry looks poised to witness solid growth in the coming years. Therefore, we think agriculture stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), Mosaic (MOS), and CF Industries (CF) are ideal buys now. However, Cronos (CRON) might be best avoided given…

StockNews.com

SEC Charges Canada's Cronos Group And Former CCO William Hilson With Accounting Fraud

Cronos Group, Inc, (NASDAQ: CRON) announced that it had reached final settlement agreements with each of the U.S.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cronos Group: Q1 Earnings Insights

Cronos Group (NASDAQ:CRON) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

A Preview Of Cronos Group's Earnings

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.08.

Benzinga

If You Invested $1,000 In Cronos Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Falling

Shares of many cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Popping Off

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Cannabis Movers & Shakers: VerdePharmHealth, Wana Brands, TILT Holdings, Flora Growth, Trees Corporation, Cronos Group

As Benzinga Cannabis Capital Conference returns (April 20-21) in Miami, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.

Benzinga

Analyst Ratings For Cronos Group

Cronos Group (NASDAQ:CRON) has observed the following analyst ratings within the last quarter:

Benzinga

Recap: Cronos Group Q4 Earnings

Cronos Group (NASDAQ:CRON) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced its 2021 fourth quarter and full-year business and financial results.

Benzinga

Thinking About Buying Stock In Pieris Pharmaceuticals, Baidu Or Cronos Group?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Benzinga

Cronos Group Earnings Preview

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.11.

1 2

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Securities and Exchange Commission

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.